Halogen-substituted aminodicarboxylic acid derivatives

US7700653B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Michael Härter · Wixom, US
• Michael Hahn · Langenfeld, DE
• Claudia Hirth-Dietrich · Wuppertal, DE
• Andreas Knorr · Erkrath, DE
• Elke Stahl · Bensberg, DE
• Johannes-Peter Stasch · Wuppertal, DE
• Frank Wunder · Wuppertal, DE

Key dates

• Filing date: Aug 22, 2005
• Grant date: Apr 20, 2010
• Expiry date: Oct 15, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to methods for treating cardiovascular disorders selected from heart failure, thromboembolic disorders, venous diseases, and fibriotic disorders other than fibrosis of the liver, comprising administering an effective amount of a compound of formula (I)wherein the several variables are as defined in the specification and claims.